Can I read Pernix Therapeutics 8-K Report Summary on EtoBox?

Pernix Therapeutics 8-K Report Summary by gilang kennard is a document available to read on EtoBox.

What is Pernix Therapeutics 8-K Report Summary about?

On February 4, 2014, Pernix Therapeutics Holdings, Inc. entered into securities purchase agreements to issue $65 million in 8.00% Convertible Senior Notes due 2019, which will be used for acquisitions and working capital. The company appointed Douglas Drysdale as the new CEO following Michael C. Pearce

Author

gilang kennard

Language

EN